| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0092 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |